Circulating regulatory T cells in endometrial cancer

A role for age and menopausal status

Saladin Sawan, Deborah J. Burt, Peter L. Stern, Cathrine Holland, Eyad Elkord

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Regulatory T cells (Treg) are a sub-population of T cells that suppress self-reactivity and are implicated in immune tolerance towards malignant cells. Circulating Treg cells are increased in several cancers. In endometrial cancer Treg cells have been investigated only in tumour tissues and, in contrast to some other tumours, fewer Treg cells were reported in endometrial cancer compared with benign controls. Flow cytometry was used to determine the frequency of circulating Treg cells in women undergoing hysterectomy for either endometrial cancer (n = 24) or non- cancer-related conditions (n = 21). Circulating Treg cells were more abundant in women with cancer compared to those without (4.68% vs. 3.66%, p = 0.05, Mann-Whitney test). This relationship disappeared, however, when only data from post-menopausal women were included in the analysis. Mean Treg cell frequency was 4.65% in postmenopausal women with cancer (n = 23) and 4.73% in postmenopausal controls (n = 5) (p = 0.9). In women without cancer we found that mean Treg cell frequency was higher in postmenopausal women (4.73%, n = 5) in comparison to premenopausal controls (3.33%, n = 16) (p = 0.02). These results suggest that the increased proportion of Treg cells seen in endometrial cancer patients might be, at least in part, attributed to their postmenopausal status or age.

Original languageEnglish
Pages (from-to)62-75
Number of pages14
JournalImmunological Investigations
Volume40
Issue number1
DOIs
Publication statusPublished - 2011
Externally publishedYes

Fingerprint

Regulatory T-Lymphocytes
Endometrial Neoplasms
Neoplasms
Immune Tolerance
Hysterectomy
Flow Cytometry
T-Lymphocytes

Keywords

  • Age
  • Endometrial cancer
  • Menopause
  • Treg cells

ASJC Scopus subject areas

  • Immunology

Cite this

Circulating regulatory T cells in endometrial cancer : A role for age and menopausal status. / Sawan, Saladin; Burt, Deborah J.; Stern, Peter L.; Holland, Cathrine; Elkord, Eyad.

In: Immunological Investigations, Vol. 40, No. 1, 2011, p. 62-75.

Research output: Contribution to journalArticle

Sawan, Saladin ; Burt, Deborah J. ; Stern, Peter L. ; Holland, Cathrine ; Elkord, Eyad. / Circulating regulatory T cells in endometrial cancer : A role for age and menopausal status. In: Immunological Investigations. 2011 ; Vol. 40, No. 1. pp. 62-75.
@article{3c42d87474ae4e70bdd44949bf4e2a11,
title = "Circulating regulatory T cells in endometrial cancer: A role for age and menopausal status",
abstract = "Regulatory T cells (Treg) are a sub-population of T cells that suppress self-reactivity and are implicated in immune tolerance towards malignant cells. Circulating Treg cells are increased in several cancers. In endometrial cancer Treg cells have been investigated only in tumour tissues and, in contrast to some other tumours, fewer Treg cells were reported in endometrial cancer compared with benign controls. Flow cytometry was used to determine the frequency of circulating Treg cells in women undergoing hysterectomy for either endometrial cancer (n = 24) or non- cancer-related conditions (n = 21). Circulating Treg cells were more abundant in women with cancer compared to those without (4.68{\%} vs. 3.66{\%}, p = 0.05, Mann-Whitney test). This relationship disappeared, however, when only data from post-menopausal women were included in the analysis. Mean Treg cell frequency was 4.65{\%} in postmenopausal women with cancer (n = 23) and 4.73{\%} in postmenopausal controls (n = 5) (p = 0.9). In women without cancer we found that mean Treg cell frequency was higher in postmenopausal women (4.73{\%}, n = 5) in comparison to premenopausal controls (3.33{\%}, n = 16) (p = 0.02). These results suggest that the increased proportion of Treg cells seen in endometrial cancer patients might be, at least in part, attributed to their postmenopausal status or age.",
keywords = "Age, Endometrial cancer, Menopause, Treg cells",
author = "Saladin Sawan and Burt, {Deborah J.} and Stern, {Peter L.} and Cathrine Holland and Eyad Elkord",
year = "2011",
doi = "10.3109/08820139.2010.513022",
language = "English",
volume = "40",
pages = "62--75",
journal = "Immunological Investigations",
issn = "0882-0139",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Circulating regulatory T cells in endometrial cancer

T2 - A role for age and menopausal status

AU - Sawan, Saladin

AU - Burt, Deborah J.

AU - Stern, Peter L.

AU - Holland, Cathrine

AU - Elkord, Eyad

PY - 2011

Y1 - 2011

N2 - Regulatory T cells (Treg) are a sub-population of T cells that suppress self-reactivity and are implicated in immune tolerance towards malignant cells. Circulating Treg cells are increased in several cancers. In endometrial cancer Treg cells have been investigated only in tumour tissues and, in contrast to some other tumours, fewer Treg cells were reported in endometrial cancer compared with benign controls. Flow cytometry was used to determine the frequency of circulating Treg cells in women undergoing hysterectomy for either endometrial cancer (n = 24) or non- cancer-related conditions (n = 21). Circulating Treg cells were more abundant in women with cancer compared to those without (4.68% vs. 3.66%, p = 0.05, Mann-Whitney test). This relationship disappeared, however, when only data from post-menopausal women were included in the analysis. Mean Treg cell frequency was 4.65% in postmenopausal women with cancer (n = 23) and 4.73% in postmenopausal controls (n = 5) (p = 0.9). In women without cancer we found that mean Treg cell frequency was higher in postmenopausal women (4.73%, n = 5) in comparison to premenopausal controls (3.33%, n = 16) (p = 0.02). These results suggest that the increased proportion of Treg cells seen in endometrial cancer patients might be, at least in part, attributed to their postmenopausal status or age.

AB - Regulatory T cells (Treg) are a sub-population of T cells that suppress self-reactivity and are implicated in immune tolerance towards malignant cells. Circulating Treg cells are increased in several cancers. In endometrial cancer Treg cells have been investigated only in tumour tissues and, in contrast to some other tumours, fewer Treg cells were reported in endometrial cancer compared with benign controls. Flow cytometry was used to determine the frequency of circulating Treg cells in women undergoing hysterectomy for either endometrial cancer (n = 24) or non- cancer-related conditions (n = 21). Circulating Treg cells were more abundant in women with cancer compared to those without (4.68% vs. 3.66%, p = 0.05, Mann-Whitney test). This relationship disappeared, however, when only data from post-menopausal women were included in the analysis. Mean Treg cell frequency was 4.65% in postmenopausal women with cancer (n = 23) and 4.73% in postmenopausal controls (n = 5) (p = 0.9). In women without cancer we found that mean Treg cell frequency was higher in postmenopausal women (4.73%, n = 5) in comparison to premenopausal controls (3.33%, n = 16) (p = 0.02). These results suggest that the increased proportion of Treg cells seen in endometrial cancer patients might be, at least in part, attributed to their postmenopausal status or age.

KW - Age

KW - Endometrial cancer

KW - Menopause

KW - Treg cells

UR - http://www.scopus.com/inward/record.url?scp=78650071023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650071023&partnerID=8YFLogxK

U2 - 10.3109/08820139.2010.513022

DO - 10.3109/08820139.2010.513022

M3 - Article

VL - 40

SP - 62

EP - 75

JO - Immunological Investigations

JF - Immunological Investigations

SN - 0882-0139

IS - 1

ER -